Shanghai Junshi Biosciences swings to FY26 H1 profit of RMB 25.5 million; revenue rises 45% to RMB 1.7 billion
Shanghai Junshi Biosciences posted revenue of RMB 1.7 billion for the six months ended June 30, up 45%. Loss for the period narrowed to RMB 36.99 million from RMB 466.41 million a year earlier. Profit attributable to owners turned to RMB 25.5 million, while basic earnings per share were RMB 0.02. R&D expenses fell 14%